Peter Söderkvist

Linköping University — Sweden

Medicine · Health Sciences

49h-index9.9kcitations251works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(26), Adrenal and Paraganglionic Tumors(26), Cancer, Hypoxia, and Metabolism(22), Cancer-related Molecular Pathways(20), Inflammasome and immune disorders(19)

Publications250 total

Integrative Epigenomic and Transcriptomic Profiling Define Malignancy- and Cluster-Specific Signatures in Pheochromocytomas and Paragangliomas
Cells·2026Open Access
P01.46.B MOLECULAR ANALYSIS OF IDH MUTATED LOW GRADE GLIOMA PROGRESSION
Neuro-Oncology·2025Open Access
Role of GDH and PARP inhibitors as novel treatments for SDHB-deficient PPGLs
Endocrine Related Cancer·2025
The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population
RMD Open·2024· 4 citedOpen Access
P10.17.A GLUTAMINE METABOLISM AS A PROGNOSTIC FACTOR IN GBM AND OLIGODENDROGLIOMA
Neuro-Oncology·2023Open Access
Relation between HLA and copy number variation of steroid 21-hydroxylase in a Swedish cohort of patients with autoimmune Addison's disease
European Journal of Endocrinology·2023· 1 citedOpen Access
Domain landscapes of somatic NF1 mutations in pheochromocytoma and paraganglioma
Gene·2023· 4 citedOpen Access
Domain Landscapes of Somatic NF1 Mutations in Pheochromocytoma and Paraganglioma
SSRN Electronic Journal·2023Open Access
Case report: Two sisters with a germline CHEK2 variant and distinct endocrine neoplasias
Frontiers in Endocrinology·2022· 6 citedOpen Access
Nuclear and mitochondrial DNA alterations in pheochromocytomas and paragangliomas, and their potential treatment
Endocrine Related Cancer·2022· 2 citedOpen Access
Implementing precision medicine in a regionally organized healthcare system in Sweden
Nature Medicine·2022· 41 cited
Methylation associated with long- or short-term survival in glioblastoma patients from the Nordic phase 3 trial
Frontiers in Genetics·2022· 9 citedOpen Access
Glucocerebrosidase variant T369M is not a risk factor for Parkinson’s disease in Sweden
Neuroscience Letters·2022· 6 citedOpen Access
Methylome analysis for prediction of long and short-term survival in glioblastoma patients from the Nordic trial
2022· 2 citedOpen Access
Genetic Alterations in Mitochondrial DNA Are Complementary to Nuclear DNA Mutations in Pheochromocytomas
Cancers·2022· 9 citedOpen Access
Loss of SDHB Induces a Metabolic Switch in the hPheo1 Cell Line toward Enhanced OXPHOS
International Journal of Molecular Sciences·2022· 25 citedOpen Access
Methylome analysis of short versus long-term GBM survivors from the Nordic randomised, phase 3 trial
WFNOS 2022 Abstract Book·2022Open Access
Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCA
Lara D. Veeken·2021· 16 citedOpen Access
P13.03 Sex-specific influence of androgen receptor gene expression on survival of glioblastoma patients
Neuro-Oncology·2021Open Access
Association of Protective HLA-A With HLA-B∗27 Positive Ankylosing Spondylitis
Frontiers in Genetics·2021· 2 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Deepti Verma(8), Jenny Welander(7), Oliver Gimm(7), Roger W. Wiseman(4), Finlay Dick(4), Mounira Hmani‐Aifa(4), Catharina Larsson(4), Martin Bäckdahl(4), Maria Lerm(4), Per Eriksson(4), Mats Fredrikson(4), Karin Fransén(4), Charles Cochran(3), Stephanie Bezzina Wettinger(3), Henrik Gréen(3), Per Rosenberg(3), Curt Peterson(3), Eva Särndahl(3), Nils Elander(3), Alf Kastbom(3)